Anthem Bioscienc

71
Buy
  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE0CZ201020
  • NSEID: ANTHEM
  • BSEID: 544449
INR
773.90
4.2 (0.55%)
BSENSE

Jul 06, 03:31 PM

BSE+NSE Vol: 2.04 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Cr
Consolidated - Profit And Loss Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
No of Months
12
12
12
12
12
12
Operating Income
2,124.00
1,844.00
1,419.00
1,056.00
1,231.00
1,103.00
Less :Inter divisional transfers
0.00
0.00
0.00
0.00
0.00
0.00
Less: Excise
0.00
0.00
0.00
0.00
0.00
0.00
Net Sales
2,124.00
1,844.00
1,419.00
1,056.00
1,231.00
1,103.00
Expenditure (Ex Depriciation)
Stock Adjustments
98.00
-86.00
-41.00
-9.00
-1.00
39.00
Raw Materials Consumed
713.00
830.00
640.00
348.00
410.00
407.00
Power & Fuel Cost
60.00
48.00
32.00
39.00
36.00
34.00
Employee Cost
282.00
260.00
182.00
153.00
137.00
142.00
Operating Expenses
43.00
41.00
30.00
21.00
23.00
22.00
General and Administration Expenses
-1.00
-1.00
-1.00
-1.00
-1.00
-1.00
Selling and Distribution Expenses
6.00
5.00
5.00
5.00
4.00
1.00
Cost of Software developments
0.00
0.00
0.00
0.00
0.00
0.00
Miscellaneous Expenses
30.00
15.00
14.00
14.00
11.00
15.00
Expenses Capitalised
0.00
0.00
0.00
0.00
0.00
0.00
Total Expenditure
1,290.00
1,173.00
914.00
628.00
666.00
695.00
Operating Profit (PBDIT) excl Other Income
833.00
670.00
504.00
428.00
565.00
407.00
Other Income
155.00
85.00
63.00
77.00
48.00
37.00
Operating Profit (PBDIT)
989.00
756.00
568.00
505.00
613.00
444.00
Interest
6.00
10.00
9.00
6.00
10.00
16.00
Profit before Depriciation and Tax
982.00
746.00
559.00
499.00
603.00
427.00
Depreciation
134.00
89.00
81.00
63.00
57.00
62.00
Profit Before Taxation & Exceptional Items
848.00
656.00
477.00
435.00
546.00
365.00
Exceptional Income / Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Profit Before Tax
824.00
656.00
477.00
497.00
546.00
365.00
Provision for Tax
232.00
205.00
110.00
112.00
140.00
94.00
Profit After Tax
591.00
451.00
367.00
385.00
405.00
271.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
Adj to Profit After Tax
0.00
0.00
0.00
0.00
0.00
0.00
Profit Balance B/F
1,922.00
1,516.00
1,220.00
873.00
607.00
336.00
Profit Available for appropriations
2,514.00
1,967.00
1,587.00
1,258.00
1,013.00
607.00
Appropriations
2,514.00
1,967.00
1,587.00
1,258.00
1,013.00
607.00
Equity Dividend (%)
100.00%
0.00%
0.00%
0.00%
0.00%
0.00%
Earnings Per Share
10.55
8.07
6.48
6.75
467.55
323.43
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2026 is 15.17% vs 29.96% in Mar 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2026 is 24.29% vs 32.84% in Mar 2025

stock-summary

Interest

YoY Growth in year ended Mar 2026 is -33.26% vs 8.33% in Mar 2025

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2026 is 31.14% vs 22.86% in Mar 2025

Compare Profit and Loss Results of Anthem Bioscienc
Markets Mojo
Figures in Cr
consolidated - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
Operating Income
2,124.00
8,939.00
-6,815.00
-76.24%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
2,124.00
8,939.00
-6,815.00
-76.24%
Expenditure (Ex Depriciation)
Stock Adjustments
98.00
-46.00
144.00
313.04%
Raw Materials Consumed
713.00
2,824.00
-2,111.00
-74.75%
Power & Fuel Cost
60.00
351.00
-291.00
-82.91%
Employee Cost
282.00
1,983.00
-1,701.00
-85.78%
Operating Expenses
43.00
814.00
-771.00
-94.72%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
6.00
532.00
-526.00
-98.87%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
30.00
304.00
-274.00
-90.13%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
1,290.00
7,210.00
-5,920.00
-82.11%
Operating Profit (PBDIT) excl Other Income
833.00
1,729.00
-896.00
-51.82%
Other Income
155.00
92.00
63.00
68.48%
Operating Profit (PBDIT)
989.00
1,821.00
-832.00
-45.69%
Interest
6.00
87.00
-81.00
-93.10%
Profit before Depriciation and Tax
982.00
1,734.00
-752.00
-43.37%
Depreciation
134.00
397.00
-263.00
-66.25%
Profit Before Taxation & Exceptional Items
848.00
1,336.00
-488.00
-36.53%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
824.00
1,131.00
-307.00
-27.14%
Provision for Tax
232.00
343.00
-111.00
-32.36%
Profit After Tax
591.00
787.00
-196.00
-24.90%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
1,922.00
4,899.00
-2,977.00
-60.77%
Profit Available for appropriations
2,514.00
5,637.00
-3,123.00
-55.40%
Appropriations
2,514.00
5,637.00
-3,123.00
-55.40%
Equity Dividend (%)
100%
400%
-300.00
Earnings Per Share
10.55
29.08
-18.53
-63.72%
Profit And Loss - Net Sales
Net Sales 2,124.33 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 15.17% vs 29.96% in Mar 2025

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 833.81 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 24.29% vs 32.84% in Mar 2025

Profit And Loss - Interest
Interest 6.89 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is -33.26% vs 8.33% in Mar 2025

Profit And Loss - Profit After Tax
Profit After Tax 591.79 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 31.14% vs 22.86% in Mar 2025